Sustained morphine treatment augments basal CGRP release from cultured primary sensory neurons in a Raf-1 dependent manner

Xu Yue, Suneeta Tumati, Edita Navratilova, Dagmar Strop, Paul A St John, Todd W Vanderah, William R Roeske, Henry I. Yamamura, Eva V. Varga

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Recent studies suggest that sustained morphine-mediated paradoxical pain may play an important role in the development of analgesic tolerance. The intracellular signal transduction pathways involved in sustained opioid mediated augmentation of spinal pain neurotransmitter (such as calcitonin gene-related peptide (CGRP)) release are not fully clarified. Cyclic AMP (cAMP)-dependent protein kinase (PKA) plays an important role in the modulation of presynaptic neurotransmitter release. Moreover, we have shown earlier that sustained opioid agonist treatment leads to a Raf-1-dependent sensitization of adenylyl cyclase(s) (AC superactivation), augmenting forskolin-stimulated cAMP formation upon opioid withdrawal (cAMP overshoot). Therefore, in the present study we examined the role of Raf-1 in sustained morphine-mediated regulation of cAMP formation and basal CGRP release in vitro, in cultured neonatal rat dorsal root ganglion (DRG) neurons. We found that sustained morphine treatment significantly augments intracellular cAMP production as well as basal CGRP release from cultured neonatal rat DRG neurons. The selective PKA inhibitor, H-89, attenuates the sustained morphine-mediated augmentation of basal CGRP release, indicating that the cAMP/PKA pathway plays an important role in regulation of CGRP release from sensory neurons. Since our present data also demonstrated that selective Raf-1 inhibitor, GW 5074, attenuated both the cAMP overshoot and the augmentation of CGRP release mediated by sustained morphine in neonatal rat DRG neurons, we suggest that Raf-1-mediated sensitization of the intracellular cAMP formation may play an important role in sustained morphine-mediated augmentation of spinal pain neurotransmitter release.

Original languageEnglish (US)
Pages (from-to)272-277
Number of pages6
JournalEuropean Journal of Pharmacology
Volume584
Issue number2-3
DOIs
StatePublished - Apr 28 2008

Fingerprint

Calcitonin Gene-Related Peptide
Sensory Receptor Cells
Cyclic AMP
Morphine
Spinal Ganglia
Opioid Analgesics
Neurotransmitter Agents
Neurons
Pain
Therapeutics
Adenylate Kinase
Colforsin
Protein Kinase Inhibitors
Cyclic AMP-Dependent Protein Kinases
Adenylyl Cyclases
Protein Kinases
Analgesics
Signal Transduction

Keywords

  • cAMP
  • CGRP
  • Dorsal root ganglion neurons
  • Morphine
  • PKA
  • Raf-1

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Sustained morphine treatment augments basal CGRP release from cultured primary sensory neurons in a Raf-1 dependent manner. / Yue, Xu; Tumati, Suneeta; Navratilova, Edita; Strop, Dagmar; St John, Paul A; Vanderah, Todd W; Roeske, William R; Yamamura, Henry I.; Varga, Eva V.

In: European Journal of Pharmacology, Vol. 584, No. 2-3, 28.04.2008, p. 272-277.

Research output: Contribution to journalArticle

Yue, Xu ; Tumati, Suneeta ; Navratilova, Edita ; Strop, Dagmar ; St John, Paul A ; Vanderah, Todd W ; Roeske, William R ; Yamamura, Henry I. ; Varga, Eva V. / Sustained morphine treatment augments basal CGRP release from cultured primary sensory neurons in a Raf-1 dependent manner. In: European Journal of Pharmacology. 2008 ; Vol. 584, No. 2-3. pp. 272-277.
@article{7a1d47d6a47046c7bf7c7fdc99d4ff19,
title = "Sustained morphine treatment augments basal CGRP release from cultured primary sensory neurons in a Raf-1 dependent manner",
abstract = "Recent studies suggest that sustained morphine-mediated paradoxical pain may play an important role in the development of analgesic tolerance. The intracellular signal transduction pathways involved in sustained opioid mediated augmentation of spinal pain neurotransmitter (such as calcitonin gene-related peptide (CGRP)) release are not fully clarified. Cyclic AMP (cAMP)-dependent protein kinase (PKA) plays an important role in the modulation of presynaptic neurotransmitter release. Moreover, we have shown earlier that sustained opioid agonist treatment leads to a Raf-1-dependent sensitization of adenylyl cyclase(s) (AC superactivation), augmenting forskolin-stimulated cAMP formation upon opioid withdrawal (cAMP overshoot). Therefore, in the present study we examined the role of Raf-1 in sustained morphine-mediated regulation of cAMP formation and basal CGRP release in vitro, in cultured neonatal rat dorsal root ganglion (DRG) neurons. We found that sustained morphine treatment significantly augments intracellular cAMP production as well as basal CGRP release from cultured neonatal rat DRG neurons. The selective PKA inhibitor, H-89, attenuates the sustained morphine-mediated augmentation of basal CGRP release, indicating that the cAMP/PKA pathway plays an important role in regulation of CGRP release from sensory neurons. Since our present data also demonstrated that selective Raf-1 inhibitor, GW 5074, attenuated both the cAMP overshoot and the augmentation of CGRP release mediated by sustained morphine in neonatal rat DRG neurons, we suggest that Raf-1-mediated sensitization of the intracellular cAMP formation may play an important role in sustained morphine-mediated augmentation of spinal pain neurotransmitter release.",
keywords = "cAMP, CGRP, Dorsal root ganglion neurons, Morphine, PKA, Raf-1",
author = "Xu Yue and Suneeta Tumati and Edita Navratilova and Dagmar Strop and {St John}, {Paul A} and Vanderah, {Todd W} and Roeske, {William R} and Yamamura, {Henry I.} and Varga, {Eva V.}",
year = "2008",
month = "4",
day = "28",
doi = "10.1016/j.ejphar.2008.02.013",
language = "English (US)",
volume = "584",
pages = "272--277",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Sustained morphine treatment augments basal CGRP release from cultured primary sensory neurons in a Raf-1 dependent manner

AU - Yue, Xu

AU - Tumati, Suneeta

AU - Navratilova, Edita

AU - Strop, Dagmar

AU - St John, Paul A

AU - Vanderah, Todd W

AU - Roeske, William R

AU - Yamamura, Henry I.

AU - Varga, Eva V.

PY - 2008/4/28

Y1 - 2008/4/28

N2 - Recent studies suggest that sustained morphine-mediated paradoxical pain may play an important role in the development of analgesic tolerance. The intracellular signal transduction pathways involved in sustained opioid mediated augmentation of spinal pain neurotransmitter (such as calcitonin gene-related peptide (CGRP)) release are not fully clarified. Cyclic AMP (cAMP)-dependent protein kinase (PKA) plays an important role in the modulation of presynaptic neurotransmitter release. Moreover, we have shown earlier that sustained opioid agonist treatment leads to a Raf-1-dependent sensitization of adenylyl cyclase(s) (AC superactivation), augmenting forskolin-stimulated cAMP formation upon opioid withdrawal (cAMP overshoot). Therefore, in the present study we examined the role of Raf-1 in sustained morphine-mediated regulation of cAMP formation and basal CGRP release in vitro, in cultured neonatal rat dorsal root ganglion (DRG) neurons. We found that sustained morphine treatment significantly augments intracellular cAMP production as well as basal CGRP release from cultured neonatal rat DRG neurons. The selective PKA inhibitor, H-89, attenuates the sustained morphine-mediated augmentation of basal CGRP release, indicating that the cAMP/PKA pathway plays an important role in regulation of CGRP release from sensory neurons. Since our present data also demonstrated that selective Raf-1 inhibitor, GW 5074, attenuated both the cAMP overshoot and the augmentation of CGRP release mediated by sustained morphine in neonatal rat DRG neurons, we suggest that Raf-1-mediated sensitization of the intracellular cAMP formation may play an important role in sustained morphine-mediated augmentation of spinal pain neurotransmitter release.

AB - Recent studies suggest that sustained morphine-mediated paradoxical pain may play an important role in the development of analgesic tolerance. The intracellular signal transduction pathways involved in sustained opioid mediated augmentation of spinal pain neurotransmitter (such as calcitonin gene-related peptide (CGRP)) release are not fully clarified. Cyclic AMP (cAMP)-dependent protein kinase (PKA) plays an important role in the modulation of presynaptic neurotransmitter release. Moreover, we have shown earlier that sustained opioid agonist treatment leads to a Raf-1-dependent sensitization of adenylyl cyclase(s) (AC superactivation), augmenting forskolin-stimulated cAMP formation upon opioid withdrawal (cAMP overshoot). Therefore, in the present study we examined the role of Raf-1 in sustained morphine-mediated regulation of cAMP formation and basal CGRP release in vitro, in cultured neonatal rat dorsal root ganglion (DRG) neurons. We found that sustained morphine treatment significantly augments intracellular cAMP production as well as basal CGRP release from cultured neonatal rat DRG neurons. The selective PKA inhibitor, H-89, attenuates the sustained morphine-mediated augmentation of basal CGRP release, indicating that the cAMP/PKA pathway plays an important role in regulation of CGRP release from sensory neurons. Since our present data also demonstrated that selective Raf-1 inhibitor, GW 5074, attenuated both the cAMP overshoot and the augmentation of CGRP release mediated by sustained morphine in neonatal rat DRG neurons, we suggest that Raf-1-mediated sensitization of the intracellular cAMP formation may play an important role in sustained morphine-mediated augmentation of spinal pain neurotransmitter release.

KW - cAMP

KW - CGRP

KW - Dorsal root ganglion neurons

KW - Morphine

KW - PKA

KW - Raf-1

UR - http://www.scopus.com/inward/record.url?scp=41249086767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41249086767&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2008.02.013

DO - 10.1016/j.ejphar.2008.02.013

M3 - Article

VL - 584

SP - 272

EP - 277

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -